Company |
Symbol |
Price Range |
Issue Price |
Open |
Shares |
Trade Date |
Apellis Pharmaceuticals | APLS - NASDAQ |
$13.00-$15.00 | $14.00 | $14.50 | 10.7 million | 11/9/2017 |
Citigroup, J.P. Morgan, Evercore ISI | ||||||
Co-Manager(s): | ||||||
Health Care | ||||||
Filing(s): 1st Filed 2015-10-14 Filed 2017-10-13 Terms added 2017-10-30 Final Prospectus 2017-11-09 |